Industry 5.0 is all about placing a higher stress on employee empowerment by making use of new technologies to offer satisfaction going beyond jobs & growth.
A slump in innovation and price rise will result if in case the antitrust laws are not put in place to prevent unlawful activities by pharmaceutical giants.
A patent lawsuit filed by the Swiss Pharma giant Roche against Biogen, the US Biotech firm for formers rheumatoid arthritis drug, Actemra has been settled.
Astellas, Pfizer as well as University of California filed a lawsuit against Sun stating that its proposed generic versions of Xtandi violated the patent law.
Quicker regulatory nods due to transparent trial registrations are some of the many advantages of the Future Clinical Trials Bill that the UK can expect.
